Efficacy of low-level laser therapy in patients with lower extremity tendinopathy or plantar fasciitis: systematic review and meta-analysis of randomised controlled trials
Naterstad IF, Joensen J, Bjordal JM, Couppé C, Lopes-Martins RAB, Stausholm MB
BMJ open · 29 citas
Cómo se estudió
- Diseño
- Metaanálisis (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Organización sin fines de lucro
- The Norwegian Fund for Post-Graduate Training for Physiotherapists
Según 1 financiador declarado y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2022-09-01 · BMJ Open · vol. 12 · número 9 · pág. e059479
- Editorial
- BMJ
- Citado
- 42 citas · más que el 86% de estudios similares · 1.7× el promedio de su campo
- Referencias
- 90 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY-NC
- Áreas de investigación
- Laser Applications in Dentistry and Medicine · Tendon Structure and Treatment · Myofascial pain diagnosis and treatment
- Palabras clave
- low-level laser therapy, tendinopathy, plantar fasciitis, lower extremity, analgesia, disability, treatment dose, exercise therapy, placebo comparison, adjunctive therapy, patient-reported outcomes, musculoskeletal disorders, risk of bias, treatment effect heterogeneity, publication bias, small sample bias, small study size bias
- MeSH
- lower extremity, humans, fasciitis, plantar, pain, tendinopathy, randomized controlled trials as topic, low-level light therapy
6 autores
- Ingvill Fjell Naterstad🇳🇴 · autor de correspondenciaUniversity of Bergen
- Jón Joensen🇳🇴University of Bergen
- Jan Magnus Bjordal🇳🇴University of Bergen
- Christian Couppé🇩🇰Bispebjerg Hospital
- Rodrigo Álvaro Brandão Lopes‐Martins🇧🇷Universidade Evangelica de Goiás
- Martin Bjørn Stausholm🇳🇴University of Bergen
Resumen
El texto original del estudio, en el idioma en que se publicó.
Objectives
We investigated the effectiveness of low-level laser therapy (LLLT) in lower extremity tendinopathy and plantar fasciitis on patient-reported pain and disability.
Design
Systematic review and meta-analysis.
Data sources
Eligible articles in any language were identified through PubMed, Embase and Physiotherapy Evidence Database (PEDro) on the 20 August 2020, references, citations and experts.
Eligibility criteria for selection of studies
Only randomised controlled trials involving participants with lower extremity tendinopathy or plantar fasciitis treated with LLLT were included.
Data extraction and synthesis
Random effects meta-analyses with dose subgroups based on the World Association for Laser Therapy treatment recommendations were conducted. Risk of bias was assessed with the PEDro scale.
Results
LLLT was compared with placebo (10 trials), other interventions (5 trials) and as an add-on intervention (3 trials). The study quality was moderate to high.Overall, pain was significantly reduced by LLLT at completed therapy (13.15 mm Visual Analogue Scale (VAS; 95% CI 7.82 to 18.48)) and 4-12 weeks later (12.56 mm VAS (95% CI 5.69 to 19.42)). Overall, disability was significantly reduced by LLLT at completed therapy (Standardised Mean Difference (SMD)=0.39 (95% CI 0.09 to 0.7) and 4-9 weeks later (SMD=0.32 (95% CI 0.05 to 0.59)). Compared with placebo control, the recommended doses significantly reduced pain at completed therapy (14.98 mm VAS (95% CI 3.74 to 26.22)) and 4-8 weeks later (14.00 mm VAS (95% CI 2.81 to 25.19)). The recommended doses significantly reduced pain as an add-on to exercise therapy versus exercise therapy alone at completed therapy (18.15 mm VAS (95% CI 10.55 to 25.76)) and 4-9 weeks later (15.90 mm VAS (95% CI 2.3 to 29.51)). No adverse events were reported.
Conclusion
LLLT significantly reduces pain and disability in lower extremity tendinopathy and plantar fasciitis in the short and medium term. Long-term data were not available. Some uncertainty about the effect size remains due to wide CIs and lack of large trials.
Prospero registration number
CRD42017077511.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.